Suvretta Capital Management, Llc

Insider Reports History

Entity
Company
Location
540 Madison Avenue, 7 Th Floor, New York, NY
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Suvretta Capital Management, Llc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Benitec Biopharma Inc. Director, 10%+ Owner Common stock, par value $0.0001 per share 955K $9.17M $9.60 Dec 3, 2024 Indirect
Benitec Biopharma Inc. Director, 10%+ Owner Common stock, par value $0.0001 per share 221K $673K $3.04 Apr 22, 2024 I
Benitec Biopharma Inc. Director, 10%+ Owner Pre-Funded Warrants 428K Sep 26, 2024 Indirect
Benitec Biopharma Inc. Director, 10%+ Owner Common Warrants 0 Sep 26, 2024 Indirect
Benitec Biopharma Inc. Director, 10%+ Owner Series 2 Common Warrants 0 Sep 26, 2024 Indirect

Insider Reports Filed by Suvretta Capital Management, Llc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BNTC Benitec Biopharma Inc. Dec 3, 2024 2 $403K 4 Dec 5, 2024 Director, 10%+ Owner
BNTC Benitec Biopharma Inc. Nov 19, 2024 4 $417K 4 Nov 21, 2024 Director, 10%+ Owner
BNTC Benitec Biopharma Inc. Sep 26, 2024 10 $21.1M 4 Sep 30, 2024 Director, 10%+ Owner
BNTC Benitec Biopharma Inc. Apr 22, 2024 0 $0 3 May 2, 2024 10%+ Owner